REGISTERED
on 28 Mar 2023
Last Applicant/ Owned by
9899 Hibert Street, Suite A
San Diego
CA
92131
Serial Number
90754981 filed on 04th Jun 2021
Registration Number
7013429 registered on 28th Mar 2023
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
MEDIPRINT OPHTHALMICS
Contact lens drug delivery devices containing pharmaceutical preparations for the treatment or prevention of diseases and conditions that affect the eye, including but not limited to allergies, astigmatism, cataracts, diabetic retinopathy, dry eye, dry eye discomfort, eye infections, eye inflammation, glaucoma, keratonconus, macular degeneration, myopia, presbyopia, hyperopia, or a combination the Read More
Classification Information
Class [005]
Pharmaceutical Products
Contact lens drug delivery devices containing pharmaceutical preparations for the treatment or prevention of diseases and conditions that affect the eye, including but not limited to allergies, astigmatism, cataracts, diabetic retinopathy, dry eye, dry eye discomfort, eye infections, eye inflammation, glaucoma, keratonconus, macular degeneration, myopia, presbyopia, hyperopia, or a combination thereof
First Use Date in General
10th Dec 2022
First Use Date in Commerce
10th Dec 2022
Mark Details
Serial Number
No 90754981
Mark Type
No Service/Collective Mark
Attorney Docket Number
No MPO_00007
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.01.18 -
Three or more concentric circles
26.01.21 -
Circles that are totally or partially shaded
26.01.31 -
Five or more circles
Legal History
| Status Date | Action Taken |
|---|---|
| 28th Mar 2023 | REGISTERED-PRINCIPAL REGISTER |
| 28th Mar 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 24th Feb 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 23rd Feb 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 01st Feb 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| 30th Jan 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 30th Dec 2022 | TEAS STATEMENT OF USE RECEIVED |
| 30th Dec 2022 | USE AMENDMENT FILED |
| 09th Aug 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 14th Jun 2022 | PUBLISHED FOR OPPOSITION |